Clinical Trial Update: Study of Pazopanib Versus Placebo as Maintenance Therapy for Advanced Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pazopanib as maintenance therapy for advanced soft tissue sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Sarcoma, Soft Tissue | Phase 2 | Status: WITHDRAWN